Search
Healthy Clinical Trials in Oklahoma City, OK
A listing of 1 Healthy clinical trials in Oklahoma City, OK actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 1 of 1
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Healthy
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
The city of Oklahoma City, Oklahoma, currently has 1 active clinical trials seeking participants for Healthy research studies.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Healthy Participants Needed (Colonoscopy + Cancer Screening)
Recruiting
Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
Conditions:
Healthy
Healthy Volunteers
Healthy Subjects
Healthy Volunteer
Healthy Participants
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Featured Trial
Healthy Volunteer Study - Case Western Reserve University
Recruiting
This Phase 1 study evaluates whether the administration of an S-nitrosylation (SNO) agent during autologous red blood cell transfusion can improve tissue oxygenation. The study investigates if replenishing S-nitrosylated hemoglobin (SNO-Hb) levels in stored blood enhances its oxygen delivery capacity. Compensation will be provided.
Conditions:
Healthy
Healthy Volunteers
Featured Trial
Get Your Lousiana Medicinal Marijuana Card (10% Off)
Recruiting
Elevate Holistics connects patients with licensed physicians who guide them through their state’s eligibility process for qualifying conditions such as chronic pain, anxiety disorders, or sleep challenges. Compassionate, compliant care every step of the way.
Use code PACSHORE10 for 10% off your consultation fee.
For adults 21+ or qualifying patients under state law. Availability varies by state.
Use code PACSHORE10 for 10% off your consultation fee.
For adults 21+ or qualifying patients under state law. Availability varies by state.
Conditions:
Anxiety
Anxiety Disorders
Generalized Anxiety Disorder
Depression
Major Depressive Disorder
Featured Trial
Get Your Massachusetts Medicinal Marijuana Card (10% Off)
Recruiting
Elevate Holistics connects patients with licensed physicians who guide them through their state’s eligibility process for qualifying conditions such as chronic pain, anxiety disorders, or sleep challenges. Compassionate, compliant care every step of the way.
Use code PACSHORE10 for 10% off your consultation fee.
For adults 21+ or qualifying patients under state law. Availability varies by state.
Use code PACSHORE10 for 10% off your consultation fee.
For adults 21+ or qualifying patients under state law. Availability varies by state.
Conditions:
Pain
Anxiety
Anxiety Disorders
Generalized Anxiety Disorder
Depression
A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).
Recruiting
Epstein Barr virus (EBV) is a virus which can cause infectious mononucleosis and is associated with certain kinds of cancer and multiple sclerosis. Researchers are looking for new ways to prevent disease related to EBV and have developed a new study vaccine (V350A and V350B). The main goal of this study is to learn about the safety and tolerability of V350A and V350B in healthy adults.
Gender:
ALL
Ages:
Between 18 years and 30 years
Trial Updated:
07/30/2025
Locations: Lynn Health Science Institute ( Site 0010), Oklahoma City, Oklahoma
Conditions: Healthy
1 - 1 of 1